Sociodemographic, Clinical, Quality of Life and Health Care Conditions in COVID-19 Survivors.
Sociodemographic,Clinical,Quality of Life, and Health Care Conditions After Hospital Discharge in Patients Who Required Admission to ICU for COVID-19 at Hospital Universitario Nacional Between April 2020 and March 2021. Bogotá, Colombia
2 other identifiers
observational
114
1 country
1
Brief Summary
Sociodemographic, Clinical, Quality of Life, and Health Care Conditions After Hospital Discharge in Patients Who Required Admission to the Intensive Care Unit for COVID-19 at the Hospital Universitario Nacional Between April 2020 and March 2021. Bogotá, Colombia The main objective of this study is to characterize the sociodemographic, clinical, quality of life and health care conditions in a cohort of patients who have survived a stay in the Intensive Care Unit of the National University Hospital of Colombia. Secondarily, associations between these findings and sociodemographic and clinical characteristics will be evaluated. It is expected to contribute to the scientific literature through the characterization and epidemiology of the problem in a sample of patients from a Latin American country. It is planned to contribute not only with clinical data, but also with data on socioeconomic impacts on patients and notions of the health care they are receiving. Through the analyzes to be carried out, associations that will contribute to the evidence for prevention and management of the outcome will be explored.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 10, 2021
CompletedFirst Submitted
Initial submission to the registry
January 7, 2022
CompletedFirst Posted
Study publicly available on registry
January 11, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 29, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2022
CompletedSeptember 27, 2022
September 1, 2022
8 months
January 7, 2022
September 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Number of participants with new or persistent symptoms after COVID-19 Number of participants with new or persistent symptoms after COVID-19
Percentage of Participants with one or more new or persistent symptoms. Assessment of the presence or absence of one or more new or persistent symptoms after having COVID-19, reported as yes or no for each symptom. If the participant manifests dyspnea, the severity will be evaluated using the Modified Medical Research Council (mMRC) instrument, with scoring options from 0 to 4. The higher score the worse the symptoms.
Baseline (At the time of the interview and application of the collection instrument)
Health-related quality of life before and after presenting COVID-19
The instrument 12-Item Short-Form Health Survey (SF-12v2) version in Spanish for Colombia will be applied. The valid questionnaire consists of 12 questions about mental and physical health. Questions will be asked for the current moment and also directed to before having COVID-19. Scores ranging from 0 to 100 with higher score indicating better health.
Baseline (At the time of the interview and application of the collection instrument)
Health care conditions after presenting COVID-19
The participants will be asked questions designed by the researchers in the collection instrument about medical controls that they have received after medical discharge from COVID-19 and mainly for new or persistent symptoms, reported as yes or no medical control. Frequency of each barrier in access to health services (by default in the collection instrument elaborated by researchers).
Baseline (At the time of the interview and application of the collection instrument)
Socioeconomic impact after presenting COVID-19
Frequency of each economic impact like salary decrease or job loss. The participants will be asked questions designed by the researchers in the collection instrument about possible personal socioeconomic impacts of having fallen ill with COVID-19 and being admitted to the Intensive Care Unit.
Baseline (At the time of the interview and application of the collection instrument)
Mental health symptoms before and after presenting COVID-19
The researchers use the valid instrument Self-Reporting Questionnaire (SRQ-20) version in Spanish. The scale consists of 20 questions to be answered: yes or no. The score ranges from 0-20, each positive answer add 1 point. Higher score indicating greater possibility of psychological distress.
Baseline (At the time of the interview and application of the collection instrument)
Functional Independence before and after presenting COVID-19
The Barthel Index, Spanish version, will be applied to assessment functional independence. Scores ranges from 0 to 100, when 100 is better outcome (independence) and 0 is worst outcome (total dependence).
Baseline (At the time of the interview and application of the collection instrument)
Study Arms (1)
COVID-19 survivors subjects
All patients discharged from the National University Hospital of Colombia (Bogotá, Colombia) who required admission to the Intensive Care Unit of the same institution with a confirmed diagnosis of SARS-CoV-2 disease (COVID-19 disease) between April 1, 2020 and March 31, 2021 * Severe Acute Respiratory Syndrome (SARS) * Coronavirus (CoV)
Interventions
Having presented Coronavirus disease 2019 (COVID-19) and stay in the Intensive Care Unit
Eligibility Criteria
: Patients admitted to the Intensive Care Unit of the Hospital Universitario Nacional de Colombia (Bogotá, Colombia) between April 1, 2020 and March 31, 2021.
You may qualify if:
- Living patients, who presented COVID-19 with admission to the Intensive Care Unit of the National University Hospital of Colombia between April 1, 2020 and March 31, 2021.
- Patients 18 years of age and older
- COVID-19 confirmed by polymerase chain reaction (PCR) test positive for SARS-CoV-19.
- Signature of informed consent
You may not qualify if:
- Missing data in the database, referring to the variables of interest
- Pregnant patients
- Limitation for communication in Spanish language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Javier Eslavalead
Study Sites (1)
Hospital Universitario Nacional de Colombia
Bogotá, 111321, Colombia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura C Loaiza-Fernandez, MD,MSc (c)
Universidad Nacional de Colombia
- PRINCIPAL INVESTIGATOR
Jairo A Pérez-Cely, MD, ICU
Hospital Universitario Nacional de Colombia / Universidad Nacional de Colombia
- PRINCIPAL INVESTIGATOR
Javier H Eslava-Schamalbach, MD, PhD
Universidad Nacional de Colombia / Hospital Universitario Nacional de Colombia
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator. Professor
Study Record Dates
First Submitted
January 7, 2022
First Posted
January 11, 2022
Study Start
September 10, 2021
Primary Completion
April 29, 2022
Study Completion
May 15, 2022
Last Updated
September 27, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data are protected by legislation and by ethical standards for research.